Epstein-Barr Virus (EBV)-Positive Post-Transplant Lymphoproliferative Disorder (PTLD) Transforming to Diffuse Large B-Cell Lymphoma with Central Nervous System (CNS) Involvement in an EBV-Seronegative Kidney Transplant Donor-Recipient Pair (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1029; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Induction included thymoglobulin with standard maintenance immunosuppression of tacrolimus, mycophenolate mofetil, and steroids...Rituximab followed by two cycles of R-CHOP was initiated...It challenges current EBV-based risk stratification paradigms, highlights the diagnostic difficulty of necrotic allograft biopsies in PTLD, and reinforces the importance of early repeat biopsy when initial tissue is inadequate. Clinicians should maintain high vigilance for PTLD regardless of pre-transplant EBV serostatus."
Post-transplantation • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Epstein-Barr Virus Infections • Genetic Disorders • Hematological Malignancies • Infectious Disease • Lymphoma • Nephrology • Non-Hodgkin's Lymphoma • Polycystic Kidney Disease • Solid Organ Transplantation • Transplantation • BCL6 • CD20 • IRF4
|
|
Nouraldin Hih; Abdelsalam Karim Soliman; Parmjeet S. Randhawa; Chethan M. Puttarajappa; Massiel Penelope Cruz Peralta; Amit D. Tevar; Susan Guthrie Wright; Nirav A. Shah; Karim Soliman
|